Skip to main content
Friday, October 16, 2026
BTC $82,274 ▲ 0.17%
GOKHSHTEIN
.
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Sections
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More Sections
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
Menu
×
News
Live Wire
Politics
World
Markets
Digital Assets
Technology
Sports
Franchises
The Brief
The Big Read
The Breakdown
Crypto Culture
More
DeFi & On-Chain
U.S. Equities
Macro & Rates
Research
Subscribe
LIVE
ADA
$0.230
up
+0.05%
ETH
$2,473
up
+1.38%
LINK
$12.61
up
+1.33%
SOL
$106.35
up
+1.00%
BTC
$82,274
up
+0.17%
XRP
$1.34
up
+0.36%
S&P 500
7,745
up
+0.01%
Nasdaq
26,579
down
−0.50%
Dow
52,335
up
+0.30%
RUT
2,763
down
−0.14%
TNX
5.08%
down
−0.16%
TYX
5.42%
down
−0.13%
FVX
4.88%
down
−0.41%
IRX
4.07%
down
−0.56%
VIX
16.08
down
−2.31%
GOLD
$4,214.60
up
+1.07%
SILVER
$57.96
up
+1.41%
OIL
$95.54
down
−0.99%
DXY
101.63
down
−0.42%
NVDA
$218.50
up
+0.58%
AAPL
$344.66
up
+0.78%
TSLA
$364.28
up
+0.51%
META
$722.45
down
−1.94%
MSFT
$536.27
down
−0.59%
AMZN
$254.07
down
−0.27%
GOOGL
$346.31
down
−0.83%
Fear & Greed
63 — Greed
ADA
$0.230
up
+0.05%
ETH
$2,473
up
+1.38%
LINK
$12.61
up
+1.33%
SOL
$106.35
up
+1.00%
BTC
$82,274
up
+0.17%
XRP
$1.34
up
+0.36%
S&P 500
7,745
up
+0.01%
Nasdaq
26,579
down
−0.50%
Dow
52,335
up
+0.30%
RUT
2,763
down
−0.14%
TNX
5.08%
down
−0.16%
TYX
5.42%
down
−0.13%
FVX
4.88%
down
−0.41%
IRX
4.07%
down
−0.56%
VIX
16.08
down
−2.31%
GOLD
$4,214.60
up
+1.07%
SILVER
$57.96
up
+1.41%
OIL
$95.54
down
−0.99%
DXY
101.63
down
−0.42%
NVDA
$218.50
up
+0.58%
AAPL
$344.66
up
+0.78%
TSLA
$364.28
up
+0.51%
META
$722.45
down
−1.94%
MSFT
$536.27
down
−0.59%
AMZN
$254.07
down
−0.27%
GOOGL
$346.31
down
−0.83%
Fear & Greed
63 — Greed
Tag
argx
1 article
U.S. Equities
20d ago
Argenx's Vyvgart Franchise Offers 23% Upside; Four Studies Coming
The biotech reported 60% year-over-year revenue growth in Q2 2026 on gMG and CIDP therapies, with Wall Street's consensus target at $1,180.25.